Risk of Infection with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis

BACKGROUND: The relative risk (RR) of infection for patients treated with immune checkpoint inhibitors (ICIs) is unknown. OBJECTIVES: This study evaluated the risk of infection for patients with solid tumors undergoing ICI therapy based on a systematic review and meta-analysis. PATIENTS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrelli, Fausto, Morelli, Anna Maria, Luciani, Andrea, Ghidini, Antonio, Solinas, Cinzia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256230/
https://www.ncbi.nlm.nih.gov/pubmed/34224061
http://dx.doi.org/10.1007/s11523-021-00824-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256230/
https://www.ncbi.nlm.nih.gov/pubmed/34224061
http://dx.doi.org/10.1007/s11523-021-00824-3

Ejemplares similares